Manufacturing Uncertainty: Contested Science and the Protection of the Publics Health and Environment
David Michaels, PhD, MPH and
Celeste Monforton, MPH
David Michaels and Celeste Monfortonis are with the Department of Environmental and Occupational Health, George Washington University School of Public Health and Health Services, Washington, DC.
Correspondence: Requests for reprints should be sent to David Michaels, PhD, Department of Environmental and Occupational Health, George Washington University School of Public Health and Health Services, 2100 M St. NW, Suite 203, Washington, DC 20037 (e-mail: eohdmm{at}gwumc.edu).
Opponents of public health and environmental regulations oftentry to "manufacture uncertainty" by questioning the validityof scientific evidence on which the regulations are based. Thoughmost identified with the tobacco industry, this strategy hasalso been used by producers of other hazardous products. Itsproponents use the label "junk science" to ridicule researchthat threatens powerful interests.
This strategy of manufacturing uncertainty is antithetical tothe public health principle that decisions be made using thebest evidence available. The public health system must ensurethat scientific evidence is evaluated in a manner that assuresthe publics health and environment will be adequatelyprotected.
This article has been cited by other articles:
J.-Y. Choi and G. Ramachandran Review of the OSHA framework for oversight of occupational environments.
J. Law Med. Ethics,
December 1, 2009;
37(4):
633 - 650.
[PDF]
N. Pearce Response: The distribution and determinants of epidemiologic research
Int. J. Epidemiol.,
February 1, 2008;
37(1):
65 - 68.
[Full Text][PDF]
N. Pearce Corporate influences on epidemiology
Int. J. Epidemiol.,
February 1, 2008;
37(1):
46 - 53.
[Abstract][Full Text][PDF]
N. Pearce Commentary: The rise and rise of corporate epidemiology and the narrowing of epidemiology's vision
Int. J. Epidemiol.,
August 1, 2007;
36(4):
713 - 717.
[Full Text][PDF]
L. Rosenstock Protecting special interests in the name of "good science".
JAMA,
May 24, 2006;
295(20):
2407 - 2410.
[Full Text][PDF]
E. Bingham, L. Boden, R. Clapp, P. Hoppin, S. Krimsky, D. Michaels, D. Ozonoff, and A. Robbins BINGHAM ET AL. RESPOND
Am J Public Health,
February 1, 2006;
96(2):
206 - 207.
[Full Text][PDF]
J. A T. Granados Response: On economic growth, business fluctuations, and health progress
Int. J. Epidemiol.,
December 1, 2005;
34(6):
1226 - 1233.
[Full Text][PDF]
D. Michaels Scientific Evidence and Public Policy
Am J Public Health,
July 1, 2005;
95(S1):
S5 - S7.
[Full Text][PDF]
P. J. Hoppin and R. Clapp Science and Regulation: Current Impasse and Future Solutions
Am J Public Health,
July 1, 2005;
95(S1):
S8 - S12.
[Abstract][Full Text][PDF]